secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2021-10-05T23:59:59+00:00
Accession:  0001013762-21-000153
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix CEO and EVP retire; CFO Matthew David named interim CEO
----------------------------------------------------------------

- Khoso Baluch retired as CEO effective Oct 4, 2021, and resigned from the Board.
- John Armstrong retired as EVP, Technical Operations, effective same date.
- CFO Matthew David appointed interim CEO; search for permanent CEO initiated with executive search firm.
- Both executives received severance per employment agreements; vested stock options exercisable up to 3 years post-retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/0001013762-21-000153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000101376221000153/ea148384-8k_cormedix.htm
  HTML page:      https://secwatch.observer/filing/0001013762-21-000153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer